Average Co-Inventor Count = 1.32
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ocuphire Pharma, Inc. (9 from 11 patents)
2. Ocularis Pharma, Inc. (3 from 6 patents)
3. Healthtech Services Corp. (1 from 15 patents)
13 patents:
1. 12016841 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
2. 11844858 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof
3. 11717510 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
4. 11400077 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
5. 11090261 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof
6. 11000509 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
7. 10993932 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
8. 10772829 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof
9. 10278918 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof
10. 9795560 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof
11. 9789088 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
12. 9089560 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
13. 5036462 - Interactive patient assistance and medication delivery systems